Voyager Therapeutics (VYGR) Tops Q3 EPS by 5c

Voyager Therapeutics (NASDAQ: VYGR) reported Q3 EPS of ($0.47), $0.05 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $13.37 million versus the consensus estimate of $7.86 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Johnson Controls (JCI) 4K contracts of August 120 puts trade, share price down 4%
• Active options: NVDA TSLA SPCX AAPL AMZN MU INTC NFLX MSFT PLTR